Edition:
United Kingdom

Glenmark Pharmaceuticals Ltd (GLEN.NS)

GLEN.NS on National Stock Exchange of India

432.85INR
19 Jul 2019
Change (% chg)

Rs-8.00 (-1.81%)
Prev Close
Rs440.85
Open
Rs440.80
Day's High
Rs446.80
Day's Low
Rs431.00
Volume
719,816
Avg. Vol
896,277
52-wk High
Rs711.90
52-wk Low
Rs423.65

About

Glenmark Pharmaceuticals Limited is a global pharmaceutical company. The Company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW). It has approximately seven molecules, over two NCEs and... (more)

Overall

Beta: 0.27
Market Cap(Mil.): Rs172,813.91
Shares Outstanding(Mil.): 282.17
Dividend: 2.00
Yield (%): 0.33

Financials

  GLEN.NS Industry Sector
P/E (TTM): 14.21 29.88 32.66
EPS (TTM): 43.09 -- --
ROI: -- 14.90 14.49
ROE: -- 16.02 15.79

BRIEF-Glenmark Pharmaceuticals To Partner With Novartis In Brazil

* GLENMARK TO PARTNER WITH NOVARTIS TO PROMOTE, COMMERCIALIZE AND DISTRIBUTE THREE RESPIRATORY PRODUCTS IN BRAZIL

24 Jun 2019

Earnings vs. Estimates